Ayşe Eda Parlak

Mrs. Ayşe Eda Parlak


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2023 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
APAyşe Eda Parlak
Ayşe Eda Parlak
ÖSÖmer Tarik Selçuk
Ömer Tarik Selçuk
GYGamze Öztürk Yilmaz
Gamze Öztürk Yilmaz
DADoğukan Aydenizoz
Doğukan Aydenizoz
NSNursel Türkoğlu Selçuk
Nursel Türkoğlu Selçuk
HEHülya Eyigör
Hülya Eyigör
Objectives: The aims of the study are to explore the morphological changes of olfactory bulb (OB) and olfactory sulcus in COVID-19 patients with associated olfactory dysfunction (OD) by measuring the OB volume (OBV) and olfactory sulcus depth (OSD) and to compare the measurement values with those of healthy individuals. Methods: Between March 2020 and January 2022, 31 consecutive hospitalized patients with a diagnosis of COVID-19 with anosmia and hyposmia who underwent brain magnetic resonance imaging and 35 normosmic control individuals were retrospectively included in the study. Bilateral OBV and OSD were measured and shape of the OB was determined based on the consensus by a neuroradiologist and an otorrhynolaryngologist. Results: The mean measurements for the right and the left sides for OBV (38 ± 8.5 and 37.1 ± 8.4, respectively) and OSD (7.4 ± 0.1 and 7.4 ± 1.0 mm, respectively) were significantly lower in COVID-19 patients with OD than those in control group (for the right and the left sides mean OBV 56.3 ± 17.1 and 49.1 ± 13.5, respectively, and mean OSD 9.6 ± 0.8 and 9.4 ± 0.8 mm, respectively). Abnormally shaped OB (lobulated, rectangular, or atrophic) were higher in patient group than those of controls. For the optimal cutoff values, OBV showed sensitivity and specificity values of 90.32% and, 57.14%, for the right, and 87.1% and 62.86% for the left side, respectively (area under the curve, 0.819 and 0.780). Olfactory sulcus depth showed sensitivity and specificity values of 90.32% and 94.29%, for the right, and 96.77% and 85.71%, for the left side, respectively (area under the curve, 0.960 and 0.944). Conclusions: Decrease in OBV and OSD measurements in COVID-19 patients with OD at the early chronic stage of the disease supports direct damage to olfactory neuronal pathways and may be used to monitor olfactory nerve renewal while returning back to normal function.

25 May 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
APAyşe Eda Parlak
Ayşe Eda Parlak
BYBurak Yangoz
Burak Yangoz
Background/Objectives: The accurate diagnosis and classification of brain tumors are critical for appropriate treatment planning and patient management. We evaluated the effectiveness of perfusion in differentiating glial tumors from metastases using dynamic susceptibility-weighted contrast enhanced perfusion MRI (DSC-MRI) Methods: A total of 95 consecutive patients with pathological diagnoses of brain tumors who underwent perfusion MRI between July 2021 and March 2023 were retrospectively recruited. Conventional and perfusion MRI were evaluated, and tumoral and peritumoral relative cerebral blood volume (rCBV) values were measured. Mann–Whitney U and Kruskal–Wallis tests were performed for non-parametric comparisons of continuous data. The optimal cut-off value of rCBV in differentiating tumor types was evaluated with the receiver operating characteristic (ROC) curve analysis. Results: Tumoral rCBV (p < 0.001) and peritumoral rCBV values (p = 0.001) were significantly higher in glial tumors than metastases. Further subgroup analyses showed that tumoral and peritumoral rCBV values of glial tumors were higher than those of non-small-cell lung cancers (p < 0.001 and p = 0.003, respectively) and those of breast cancer (p = 0.311 and p = 0.053, respectively) in discriminating high-grade glial tumors and metastases. ROC analyses showed that area under the curve values for tumoral and peritumoral rCBV were 0.816 and 0.725, respectively, for the optimal cut-off points 1.339 and 1.238 (87.5% and 58.33% sensitivity; 73.85% and 90.77% specificity, respectively). Multivariate analysis showed that increased tumoral rCBV and peritumoral rCBV values were independent risk factors for glial tumor occurrence. Conclusions: DSC-MRI is an effective method to differentiate glial tumors and metastases. Higher rCBV values may serve as a determinant for the diagnosis of glial tumors and metastatic brain tumors.

23 September 2024 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
APAyşe Eda Parlak
Ayşe Eda Parlak
OGOzlem Vardar Gok
Ozlem Vardar Gok
ITIclal Erdem Toslak
Iclal Erdem Toslak
RBRiza Taner Baran
Riza Taner Baran
MPMesut Parlak
Mesut Parlak

3 November 2022 in The European Research Journal
Verified
Journal Article
Open access
PDF file
APAyşe Eda Parlak
Ayşe Eda Parlak
BYBuket Yağcı
Buket Yağcı
Objectives: The purpose the study was to evaluate the role of diffusion weighted magnetic resonance imaging (DW-MRI) in diagnosis of benign and malignant breast lesions, to calculate a cut-off apparent diffusion coefficient (ADC) value and to explore use of relative ADC (r ADC) for improving sensitivity and specificity of MRI in diagnosis of breast cancer. Methods: This retrospective study based on a cohort of patients who underwent dynamic contrast enhanced (DCE)-MRI having suspicious breast mass by ultrasonography and mammography to whom DWI sequence was added to the routine diagnostic MRI. ADC and r ADC (lesion/normal breast tissue) values of breast masses were calculated. The threshold ADC values used to differentiate benign and malignant lesions were determined using receiver operating characteristic analysis, sensitivity, specificity, positive predictive value and negative predictive value were calculated. Results: Malignant masses had significantly lower ADC (mean: 1.03 ± 0.36 × 10-3 mm2/s) and r ADC (mean: 0.66 ± 0.22 × 10-3 mm2/s) values than those of benign masses with ADC (mean: 1.50 ± 0.56 × 10−3 mm2/s) and r ADC (mean: 0.97 ± 0.31 × 10-3 mm2/s) values, respectively (p = 0.001 for both). The best cut-off value for the lesion ADC was 1.09 × 10-3 mm2/s with a sensitivity of 72.73%, and specificity of 79.17%. The best cut-off value for r ADC was 0.83 with sensitivity of 78.79% and specificity of 70.83%. Conclusions: DWI has high diagnostic value with high sensitivity and specificity differentiating benign and malignant breast lesions. ADC and r ADC values can improve the diagnostic accuracy of differentiating benign and malignant breast lesions.

6 September 2024 in Die Radiologie
Verified
Journal Article
Closed access
PDF file
DTDevrim Toslak
Devrim Toslak
MEMuhammet Kazim Erol
Muhammet Kazim Erol
APAyşe Eda Parlak
Ayşe Eda Parlak
MBMehmet Bulut
Mehmet Bulut
ITIclal Erdem Toslak
Iclal Erdem Toslak